F4 FORUM
Organised by Coordination & Support Action (CSA) PerMed, Seventh Framework Project
(EU Grant No. 602139)
Personalised Medicine (PM) is one of the most innovative areas in the future of health research. Its high potential, for patients, citizens and the economy, is not being fully realised due to fragmented activities, insufficient communication and lack of generic solutions. Implementation of PM is, therefore, a key challenge in Europe and beyond.
The EU-funded Coordination & Support Action PerMed was initiated to step up stakeholder coordination to allow synergies and avoid duplication or competition, and ensure maximum transparency to equip Europe to lead the world. Its aim is to develop recommendations to foster the implementation of PM in transnational research and health systems.
PerMed recommendations
Angela Brand, Professor, University Maastricht, the Netherlands
Erika Hackenitz, The Netherlands Organisation for Health Research and Development (ZonMw)
Lada Leyens, University Maastricht, the Netherlands
Early dialogue and regulatory aspects
Falk Ehmann, European Medicines Agency (EMA), UK
Legal and ethical aspects
Effy Vayena, University of Zurich, Switzerland
Citizens’ perspective and needs
Kaisa Immonen-Charalambous, European Patients' Forum (EPF)
A hospital’s perspective
AL Andreu Periz, Instituto de Salud Carlos III, Spain
The General Practitioner's perspective
Ferenc Hajnal, European Union of General Practitioners (UMEO), Hungary
Best practice example – Rare diseases
Christoph Klein, University Munich, Germany
Best practice example – Nutrition
Andre Boorsma, Netherlands Organisation for Applied Scientific Research (TNO), the Netherlands
Moderation
Clive Cookson, Journalist, Financial Times